Codexis, Inc. (CDXS) vs Neuronetics, Inc. (STIM)
A side-by-side comparison of Codexis, Inc. and Neuronetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDXS
Codexis, Inc.
$1.39HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
STIM
Neuronetics, Inc.
$2.22HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — CDXS vs STIM
growth of $100 · dividends reinvested · last 8yCDXS -90.0% (-25.0%/yr)STIM -92.1% (-27.2%/yr)CDXS compounded faster over this window
CDXS STIM
CDXS vs STIM: by the numbers
- •STIM is the larger company ($154M vs $149M market cap).
- •Both run net losses; STIM's is the smaller (-19.62% vs -39.55% net margin).
- •STIM grew revenue faster over the past five years (23.26% vs 0.38% CAGR).
Metrics side by side
Valuation
| Metric | CDXS | STIM |
|---|---|---|
| P/S ratio | 1.92 | 0.99 |
| P/B ratio | 4.52 | 8.64 |
Profitability
| Metric | CDXS | STIM |
|---|---|---|
| Gross margin | 83.71% | 49.12% |
| Operating margin | -54.46% | -14.74% |
| Net margin | -39.55% | -19.62% |
| ROE | -93.22% | -170.49% |
| ROIC | -23.41% | -22.15% |
Growth (annualized)
| Metric | CDXS | STIM |
|---|---|---|
| Revenue CAGR (5Y) | 0.38% | 23.26% |
| Total return CAGR (5Y) | -44.64% | -19.46% |
Frequently asked
- Which has grown faster, CDXS or STIM?
- Over the past five years, STIM grew revenue faster — CDXS at a 0.38% CAGR versus STIM at 23.26%.
- How have CDXS and STIM total returns compared?
- Over the past 5 years, CDXS delivered -44.64% and STIM delivered -19.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Codexis ROENeuronetics ROECodexis operating marginNeuronetics operating marginCodexis revenue growthNeuronetics revenue growthCodexis free cash flowNeuronetics free cash flow
Codexis & Neuronetics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.